Literature DB >> 4061324

Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease.

H Nakano, K Ueda, A Saito, K Nojima.   

Abstract

Accurate evaluation of the extent of coronary artery lesions complicating Kawasaki disease is clinically important in patient management. Based on a total of 188 coronary angiograms and retrospective follow-up observations, the condition of coronary aneurysms was quantitatively graded as: 0 (normal)--no significant enlargement in any portion of the coronary artery; I (mild)--aneurysmal dilatation of the coronary artery evident but localized, with a maximal diameter of less than 4.0 mm; II (moderate)--maximal diameter of coronary aneurysms between 4.0 and 8.0 mm, regardless of body size; III (severe)--giant aneurysms, with the maximal diameter greater than 8.0 mm. Most mild coronary aneurysms regressed to normal within a short time, and the patient's prognosis was good. The course of grade II aneurysms varied, depending on initial angiographic coronary diameter, but all were eventually reduced in coronary size. In contrast, grade III aneurysms usually progressed to become obstructive or stenotic coronary lesions, or the large aneurysm persisted. Follow-up observations revealed that the course of coronary artery disease depended on the size and distribution of aneurysms at initial angiography. This grading of the severity of coronary lesions may provide useful criteria for predicting the prognosis of patients with Kawasaki disease.

Entities:  

Mesh:

Year:  1985        PMID: 4061324     DOI: 10.1016/0002-9149(85)90767-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  35 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease.

Authors:  E Tsuda; T Kamiya; Y Ono; K Kimura; K Kurosaki; S Echigo
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

3.  Anesthetic management of the patient with a history of Kawasaki disease--a report of 19 cases.

Authors:  Y Kojima; Y Kitahara; F Nozaki
Journal:  J Anesth       Date:  1990-04       Impact factor: 2.078

4.  Midterm outcome of percutaneous transcatheter coil occlusion of coronary artery fistula.

Authors:  Chi-D Liang; Sheung F Ko
Journal:  Pediatr Cardiol       Date:  2006-08-30       Impact factor: 1.655

5.  Small bowel pseudo-obstruction in Kawasaki disease.

Authors:  T Miyake; J Kawamori; T Yoshida; H Nakano; S Kohno; S Ohba
Journal:  Pediatr Radiol       Date:  1987

Review 6.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

7.  Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.

Authors:  Fabienne Mueller; Walter Knirsch; Paul Harpes; René Prêtre; Emanuela Valsangiacomo Buechel; Oliver Kretschmar
Journal:  Clin Res Cardiol       Date:  2009-06-05       Impact factor: 5.460

8.  Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

Authors:  M Fukazawa; J Fukushige; T Takeuchi; H Narabayashi; H Igarashi; T Hijii; K Ueda; Y Kuwabara; M Otsuka; Y Ichiya
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

9.  Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.

Authors:  Chantale Lapierre; Audrey Bitsch; Ronald Guérin; Laurent Garel; Joaquim Miró; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

10.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.